V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002239 | 330001258 | 1.77 | 20.7 | Curative (C) | 2018-01-09 | 2018-01-11 | Cisplatin | N | N | 330008322 | CISPLATIN |
| 330002240 | 330001258 | 1.74 | 82.5 | Curative (C) | 2013-06-03 | 2013-06-27 | Cisplatin | 02 | Y | 330008322 | CISPLATIN |
| 330002241 | 330001258 | 1.54 | 35.9 | Neo-adjuvant (N) | null | 2017-06-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330008322 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002242 | 330001258 | 1.82 | null | Curative (C) | 2017-07-09 | 2017-07-09 | Cisplatin | N | Y | 330008322 | CISPLATIN |
| 330002243 | 330001259 | 1.72 | 21 | Curative (C) | 2014-06-26 | 2014-06-26 | Cisplatin 7 day | 02 | Y | 330008330 | CISPLATIN |
| 330002244 | 330001260 | 1.8 | 47.8 | Curative (C) | 2015-03-03 | 2015-03-30 | Cisplatin | 02 | Y | 330008332 | CISPLATIN |
| 330002245 | 330001261 | null | 60.8 | Curative (C) | 2018-01-02 | 2018-01-23 | Cisplatin 7 day | 2 | Y | 330008339 | CISPLATIN |
| 330002246 | 330001262 | null | 11.5 | Curative (C) | 2017-01-13 | 2017-01-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008342 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002247 | 330001263 | null | 67.25 | Curative (C) | 2017-02-26 | 2017-02-27 | LI-1 TRIAL | Y | N | 330008343 | TRIAL |
| 330002249 | 330006670 | 1.76 | 82 | Curative (C) | 2012-05-25 | 2016-06-05 | Cisplatin 7 day | N | Y | 330008350 | CISPLATIN |
| 330002250 | 330009600 | 1.52 | 56.8 | Neo-adjuvant (N) | 2015-05-23 | 2015-06-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330008351 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002251 | 330009600 | 0 | 45.1 | Curative (C) | 2017-09-11 | 2018-02-19 | null | null | N | 330008351 | NOT MATCHED |
| 330002254 | 330001266 | null | 9.1 | Curative (C) | 2017-07-06 | 2017-07-07 | EW Rel rEECur Topotecan/Cyclophosphamide | Y | N | 330008370 | NOT MATCHED |
| 330002255 | 330001267 | 1.8 | null | Neo-adjuvant (N) | null | 2015-03-23 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330008371 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002256 | 330001268 | null | 8.6 | Neo-adjuvant (N) | 2016-03-20 | 2016-03-26 | Trial Unspecified | Y | N | 330008372 | TRIAL |
| 330002257 | 330001268 | 1.77 | 87.4 | Curative (C) | 2017-12-11 | 2017-12-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330008372 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002258 | 330009601 | 1.7 | 123.2 | Adjuvant (A) | 2016-12-12 | 2016-12-26 | Cisplatin | null | Y | 330008381 | CISPLATIN |
| 330002259 | 330001269 | null | 85.6 | Curative (C) | 2016-12-05 | 2016-12-06 | CNS Medbl Std Risk Maint Cisplatin | N | N | 330008382 | CISPLATIN |
| 330002260 | 330006673 | null | 77.5 | Curative (C) | 2015-04-04 | 2015-04-07 | NB HRNBL | Y | N | 330008383 | NOT MATCHED |
| 330002261 | 330001270 | 1.79 | 12.9 | Curative (C) | null | 2013-11-26 | Cisplatin | 02 | Y | 330008384 | CISPLATIN |
| 330002263 | 330001272 | 1.6 | 12.4 | Curative (C) | 2013-12-07 | 2013-12-25 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330008390 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002264 | 330001272 | 1.63 | 12 | Curative (C) | 2016-05-05 | 2016-05-05 | Cisplatin 7 day | N | Y | 330008390 | CISPLATIN |
| 330002265 | 330001273 | 1.8 | 77 | null | null | 2015-05-27 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330008395 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002266 | 330001273 | 1.56 | null | Curative (C) | 2013-06-10 | 2013-06-23 | Cisplatin 7 day | N | Y | 330008395 | CISPLATIN |
| 330002267 | 330001274 | null | 13.4 | Neo-adjuvant (N) | null | 2016-11-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330008397 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002268 | 330001275 | 1.8 | 74.4 | Neo-adjuvant (N) | 2014-05-18 | 2014-05-19 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330008399 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002269 | 330001275 | 1.62 | 85.7 | Curative (C) | 2013-12-19 | 2013-12-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 330008399 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002270 | 330001276 | 1.82 | 101.2 | Palliative (P) | 2016-10-04 | 2016-10-17 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330008412 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002272 | 330001278 | 1.83 | 75.8 | Disease modification (D) | 2016-01-14 | 2016-01-20 | Bendamustine+Rituximab(Sub Courses) | N | N | 330008416 | BENDAMUSTINE + RITUXIMAB |
| 330002273 | 330001279 | 1.68 | 67.2 | null | 2013-06-17 | 2013-07-14 | Cisplatin + Doxorubicin | N | N | 330008417 | CISPLATIN + DOXORUBICIN |
| 330002274 | 330001280 | 1.64 | 53 | Palliative (P) | 2015-12-11 | 2015-12-17 | CARBOPLATIN + PACLITAXEL | N | N | 330008427 | CARBOPLATIN + PACLITAXEL |
| 330002275 | 330001280 | 1.76 | 57.8 | Palliative (P) | 2016-12-13 | 2016-12-20 | DOXORUBICIN | N | N | 330008427 | DOXORUBICIN |
| 330002276 | 330001281 | 1.64 | 68 | Palliative (P) | 2014-10-14 | 2014-10-18 | DOXORUBICIN | N | N | 330008431 | DOXORUBICIN |
| 330002277 | 330001282 | 1.85 | 74 | Palliative (P) | null | 2013-11-27 | Doxorubicin 75mg/m2 | N | N | 330008432 | DOXORUBICIN |
| 330002278 | 330001283 | 1.69 | 64 | Palliative (P) | 2013-10-21 | 2013-10-24 | Liposomal Doxorubicin 40mg/m2 | N | N | 330008436 | LIPOSOMAL DOXORUBICIN |
| 330002279 | 330001284 | 1.84 | 70 | null | 2017-02-13 | 2017-02-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330008439 | CARBOPLATIN + PACLITAXEL |
| 330002280 | 330006678 | 1.67 | null | Palliative (P) | 2018-01-09 | 2018-01-22 | CARBOPLATIN + PACLITAXEL | 2 | null | 330008443 | CARBOPLATIN + PACLITAXEL |
| 330002281 | 330006678 | 1.65 | 76.5 | Curative (C) | 2017-02-19 | 2017-02-26 | Rituximab | N | N | 330008443 | RITUXIMAB |
| 330002282 | 330001285 | 1.67 | 102 | Palliative (P) | 2017-12-22 | 2017-12-22 | DOXORUBICIN | 02 | N | 330008458 | DOXORUBICIN |
| 330002283 | 330006679 | 1.72 | 70 | Curative (C) | null | 2014-09-25 | CARBOPLATIN + PACLITAXEL | null | null | 330008460 | CARBOPLATIN + PACLITAXEL |
| 330002284 | 330001286 | 1.61 | 53 | null | 2014-02-18 | 2014-02-18 | Carboplatin AUC 6 - 10 | 2 | null | 330008461 | CARBOPLATIN |
| 330002285 | 330001286 | 1.48 | 63 | Not known (9) | 2013-09-06 | 2013-09-13 | Liposomal Doxorubicin (Caelyx) | N | N | 330008461 | LIPOSOMAL DOXORUBICIN |
| 330002286 | 330001286 | 1.6 | 89 | Curative (C) | 2016-09-14 | 2016-10-14 | Carboplatin + Etoposide IV 3 day | N | N | 330008461 | CARBOPLATIN + ETOPOSIDE |
| 330002287 | 330001287 | 1.69 | 91.6 | Curative (C) | 2014-06-07 | 2014-06-10 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 330008467 | LIPOSOMAL DOXORUBICIN |
| 330002288 | 330001288 | 1.66 | 75.8 | Palliative (P) | 2015-11-22 | 2015-12-04 | Cisplatin + Doxorubicin | N | N | 330008473 | CISPLATIN + DOXORUBICIN |
| 330002289 | 330001289 | 1.7 | 84.6 | Adjuvant (A) | 2015-05-19 | 2015-05-26 | CARBOPLATIN | null | N | 330008475 | CARBOPLATIN |
| 330002292 | 330001292 | 1.73 | 85.5 | Palliative (P) | 2014-07-26 | 2014-08-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330008483 | CARBOPLATIN + PACLITAXEL |
| 330002294 | 330001294 | 1.8 | 75.4 | Disease modification (D) | 2014-05-15 | 2014-05-21 | Bendamustine+Rituximab (1st Course) | N | N | 330008492 | BENDAMUSTINE + RITUXIMAB |
| 330002295 | 330001295 | 1.84 | 83.65 | Not known (9) | 2017-12-22 | 2018-01-02 | Liposomal Doxorubicin (Caelyx) | N | N | 330008495 | LIPOSOMAL DOXORUBICIN |
| 330002296 | 330006681 | 1.57 | 43.8 | Palliative (P) | 2015-06-11 | 2015-06-29 | DOXORUBICIN | N | N | 330008497 | DOXORUBICIN |